Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 29;12(13):4376.
doi: 10.3390/jcm12134376.

Adipokines as Predictive Biomarkers for Training Adaptation in Subjects with Multimorbidity-A Hypothesis-Generating Study

Affiliations

Adipokines as Predictive Biomarkers for Training Adaptation in Subjects with Multimorbidity-A Hypothesis-Generating Study

Felipe Mattioni Maturana et al. J Clin Med. .

Abstract

Background: Physical exercise exerts a positive effect on many chronic conditions, specifically lifestyle-related diseases such as overweight and obesity, type 2 diabetes mellitus (T2DM), cardiovascular conditions and osteoarthritis (OA). As a result of common risk factors, most of these patients present with multiple conditions. Exercise- and disease-related biomarkers, such as adipokines, are emerging tools in training supervision and regulation; however, their significance in subjects with multimorbidities is unknown.

Subjects and methods: To address this issue, adipokines leptin, adiponectin and resistin were assessed in a cohort of subjects with multimorbidities (n = 39) presenting with at least two of the abovementioned conditions or relevant risk factors before and after a six-month exercise and lifestyle intervention program ('MultiPill-Exercise'), and correlated with training adaptation, namely changes in relative maximum oxygen uptake (V·O2max).

Results: There was a significant negative correlation between baseline leptin concentrations and training effect for relative V·O2max (after three months: rho = -0.54, p = 0.020 *; after six months: rho = -0.45, p = 0.013 *), with baseline leptin explaining 35% of the variance in delta relative V·O2max after three months and 23% after six months.

Conclusions: Leptin might be a suitable surrogate biomarker in the context of exercise-based lifestyle intervention programs in subjects with multimorbidity.

Keywords: adipokines; leptin; multimorbidity; obesity; physical exercise.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Correlation between baseline adipokine concentrations and baseline V·O2max. Scatter plots with fitted regression line and 95% confidence interval band show correlations between adipokine concentrations at baseline and baseline (relative and absolute) V·O2max.
Figure 2
Figure 2
Correlation between baseline adipokine concentrations and changes in V·O2max. Scatter plots with fitted regression line and 95% confidence interval band show correlations between adipokine concentrations at baseline and changes in (relative) V·O2max. * p < 0.05.
Figure 3
Figure 3
Correlation between changes in adipokine concentrations and changes in V·O2max. Scatter plots with fitted regression line and 95% confidence interval band show correlations between changes in adipokine concentrations and changes in (relative) V·O2max. * p < 0.05.
Figure 4
Figure 4
Correlation between changes in leptin concentrations and changes in absolute V·O2max. Scatter plots with fitted regression line and 95% confidence interval band show correlations between changes in leptin concentrations and changes in absolute V·O2max.

Similar articles

Cited by

References

    1. Blüher M. Obesity: Global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 2019;15:288–298. doi: 10.1038/s41574-019-0176-8. - DOI - PubMed
    1. Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14:88–98. doi: 10.1038/nrendo.2017.151. - DOI - PubMed
    1. Saglietto A., Manfredi R., Elia E., D’Ascenzo F., GM D.F., Biondi-Zoccai G., Munzel T. Cardiovascular disease burden: ITALIAN and global perspectives. Minerva Cardiol. Angiol. 2021;69:231–240. doi: 10.23736/S2724-5683.21.05538-9. - DOI - PubMed
    1. Kloppenburg M., Berenbaum F. Osteoarthritis year in review 2019: Epidemiology and therapy. Osteoarthr. Cartil. 2020;28:242–248. doi: 10.1016/j.joca.2020.01.002. - DOI - PubMed
    1. Xu X., Mishra G.D., Jones M. Evidence on multimorbidity from definition to intervention: An overview of systematic reviews. Ageing Res. Rev. 2017;37:53–68. doi: 10.1016/j.arr.2017.05.003. - DOI - PubMed